Dearborn Partners Portfolio holdings
Dearborn Partners builds portfolios of companies it expects to keep raising their dividends, an approach it calls its Rising Dividend strategy. Three Chicago investment managers who wanted to offer more personal service joined together to form the firm in 1997. Carol Lippman, who began formulating the Rising Dividend approach in 1993 at another firm, joined in 2011 and manages the strategy, with Michael Andelman as co-portfolio manager. Dearborn also advises the Dearborn Partners Rising Dividend Fund, a mutual fund, and serves financial advisors, high net worth families and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$5.62M |
| 2 |
Chevron
CVX
|
+$3.27M |
| 3 |
Baxter International
BAX
|
+$2.54M |
| 4 |
Xcel Energy
XEL
|
+$1.04M |
| 5 |
Travelers Companies
TRV
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$3.32M |
| 2 |
Visa
V
|
+$2.56M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$2.47M |
| 4 |
Steris
STE
|
+$2.41M |
| 5 |
LABL
Multi-Color Corp
LABL
|
+$2.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.74% |
| 2 | Healthcare | 14.04% |
| 3 | Industrials | 13.88% |
| 4 | Consumer Staples | 10.56% |
| 5 | Energy | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Novartis
NVS
$303B
| $28.3M | 2.73% |
321,319
-193
| -0.1% | -$17.7K |
2013 Q2
8 quarters
|
|
2
Johnson & Johnson
JNJ
$688B
| $26.3M | 2.54% |
270,028
-4,201
| -2% | -$421K |
2013 Q2
8 quarters
|
|
3
Illinois Tool Works
ITW
$81.7B
| $23.6M | 2.27% |
256,960
-2,813
| -1% | -$268K |
2013 Q2
8 quarters
|
|
4
Apple
AAPL
$5.18T
| $23.6M | 2.27% |
751,172
-61,896
| -8% | -$1.98M |
2013 Q2
8 quarters
|
|
5
Becton Dickinson
BDX
$59.4B
| $22.8M | 2.2% |
165,113
+6,272
| +4% | +$866K |
2013 Q2
8 quarters
|
|
6
General Mills
GIS
$18.4B
| $22.5M | 2.17% |
404,520
+14,600
| +4% | +$818K |
2013 Q2
8 quarters
|
|
|
7
Chevron
CVX
$429B
| $22.4M | 2.16% |
232,305
+31,181
| +16% | +$3.27M |
2013 Q2
8 quarters
|
|
8
3M
MMM
$94.7B
| $21.4M | 2.06% |
165,842
+4,459
| +3% | +$598K |
2013 Q2
8 quarters
|
|
9
McDonald's
MCD
$192B
| $20.1M | 1.94% |
211,325
+5,776
| +3% | +$559K |
2013 Q2
8 quarters
|
|
|
10
IBM
IBM
$234B
| $19.7M | 1.9% |
126,839
+34,965
| +38% | +$5.62M |
2013 Q2
8 quarters
|
|
11
Automatic Data Processing
ADP
$122B
| $19.6M | 1.89% |
244,009
-8,792
| -3% | -$750K |
2013 Q2
8 quarters
|
|
12
Qualcomm
QCOM
$185B
| $17.7M | 1.71% |
282,983
+8,075
| +3% | +$551K |
2013 Q2
8 quarters
|
|
13
VF Corp
VFC
$8.14B
| $17.7M | 1.71% |
269,424
-7,949
| -3% | -$538K |
2013 Q2
8 quarters
|
|
14
DELISTED
EMC CORPORATION
EMC
| $16.9M | 1.63% |
641,295
+8,589
| +1% | +$229K |
2013 Q2
8 quarters
|
|
15
AT&T
T
$149B
| $16.2M | 1.56% |
604,488
+416
| +0.1% | +$10.8K |
2013 Q2
8 quarters
|
|
16
Coca-Cola
KO
$427B
| $16M | 1.54% |
406,893
+5,169
| +1% | +$210K |
2013 Q2
8 quarters
|
|
17
DELISTED
Valspar
VAL
| $15.8M | 1.52% |
193,230
+7,569
| +4% | +$634K |
2013 Q2
8 quarters
|
|
18
RTX Corp
RTX
$268B
| $15.8M | 1.52% |
225,628
+6,383
| +3% | +$468K |
2013 Q2
8 quarters
|
|
|
19
Steris
STE
$25.7B
| $15.7M | 1.52% |
244,155
-35,772
| -13% | -$2.41M |
2013 Q2
8 quarters
|
|
20
ExxonMobil
XOM
$696B
| $15.6M | 1.51% |
187,784
-5,569
| -3% | -$479K |
2013 Q2
8 quarters
|
|
21
Kinder Morgan
KMI
$71.1B
| $14.6M | 1.41% |
381,121
-8,527
| -2% | -$356K |
2013 Q2
8 quarters
|
|
22
Kimberly-Clark
KMB
$67.2B
| $14.3M | 1.38% |
135,225
-902
| -0.7% | -$98.2K |
2013 Q2
8 quarters
|
|
23
United Parcel Service
UPS
$95.7B
| $14.2M | 1.37% |
146,960
+9,560
| +7% | +$950K |
2013 Q2
8 quarters
|
|
24
Republic Services
RSG
$77.1B
| $13.5M | 1.3% |
344,401
+10,507
| +3% | +$423K |
2013 Q2
8 quarters
|
|
25
Realty Income
O
$55.9B
| $12.6M | 1.22% |
293,917
+12,696
| +5% | +$581K |
2013 Q2
8 quarters
|
|
Similar funds
Dearborn Partners's Q2 2015 Portfolio in Review
As of Q2 2015, Dearborn Partners held 302 positions worth $1.04B, down 9.3% from $1.14B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Dearborn Partners withdrew a net $79.2M in Q2 2015, closing 84 positions and reducing 137 holdings. Its most notable exit was Cambrex Corporation, an estimated $2.47M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Dearborn Partners opened a new position in Vanguard FTSE Developed Markets ETF worth $567K.
- Dearborn Partners's largest Q2 2015 buy was Vanguard FTSE Developed Markets ETF: 14,295 shares worth $567K.
- Dearborn Partners added most to IBM in Q2 2015, an estimated $5.62M increase.
- Dearborn Partners's biggest Q2 2015 reduction was Procter & Gamble, cutting an estimated $3.32M.
- Dearborn Partners fully exited Cambrex Corporation in Q2 2015, selling an estimated $2.47M.
- Dearborn Partners's ten largest holdings make up 22% of its $1.04B portfolio in Q2 2015.
- Dearborn Partners opened 8 new positions and closed 84 in Q2 2015.
- Dearborn Partners's portfolio value fell 9.3% quarter-over-quarter to $1.04B.
Based on Dearborn Partners's 13F filing for Q2 2015, filed 13 Aug 2015.